Enlivex Therapeutics (NASDAQ:ENLV) Earns Buy Rating from D. Boral Capital
Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $13.00 price objective on the stock. Enlivex Therapeutics Trading Up 5.9 % Shares of Enlivex Therapeutics stock opened […]
Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $13.00 price objective on the stock. Enlivex Therapeutics Trading Up 5.9 % Shares of Enlivex Therapeutics stock opened […]
